BRIEF published on 09/23/2024 at 18:05, 5 days 6 hours ago Half-year results 2024: genOway achieves its growth objectives EBITDA Biotechnology Strategic Plan R&D Growth
BRIEF published on 07/18/2024 at 18:05, 2 months 10 days ago GenOway shows growth of 15% in the first half of 2024 Sales Growth Preclinical GenOway Route50+
BRIEF published on 07/04/2024 at 18:05, 2 months 24 days ago Half-yearly review of the GENOWAY liquidity contract Liquidity Transactions BNP Paribas GenOway Half-yearly Review
BRIEF published on 06/25/2024 at 18:00, 3 months 3 days ago Promising development for the genOway Shanghai joint venture Joint Venture China Immuno-oncology Preclinical Research GenOway
Published on 09/28/2024 at 02:06, 22 hours 19 minutes ago Global Education Communities Corp. Reports Second Tranche Closing of Non-Brokered Private Placement
Published on 09/28/2024 at 02:00, 22 hours 25 minutes ago Quantum Biopharma Provides Corporate Update
Published on 09/28/2024 at 02:00, 22 hours 25 minutes ago bettermoo(d)’s Moodrink(TM) Featured in Banners of Well-Known Canadian Retailers
Published on 09/28/2024 at 00:10, 1 day ago LQWD Technologies Announces Non-Brokered Private Placement Update
Published on 09/28/2024 at 14:01, 10 hours 24 minutes ago Turkiye Garanti Bankasi A.S.: Explanation on Subordinated Debt Securities to Qualified Investors
Published on 09/27/2024 at 22:30, 1 day 1 hour ago DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Published on 09/27/2024 at 21:56, 1 day 2 hours ago EQS-Adhoc: FDA grants approval for Stelara® Biosimilar FYB202/OtulfiTM (ustekinumab-aauz)
Published on 09/27/2024 at 18:50, 1 day 5 hours ago PETROFAC ANNOUNCES IN-PRINCIPLE AGREEMENT ON FINANCIAL RESTRUCTURE
Published on 09/27/2024 at 18:40, 1 day 5 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/27/2024 at 17:45, 1 day 6 hours ago NFL BIOSCIENCES: 2024 FIRST-HALF BUSINESS AND EARNINGS UPDATE
Published on 09/26/2024 at 18:00, 2 days 6 hours ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2024
Published on 09/26/2024 at 18:00, 2 days 6 hours ago GUILLEMOT CORPORATION: 2024 CONSOLIDATED INTERIM RESULTS
Published on 09/26/2024 at 17:47, 2 days 6 hours ago imerys-26-September-2024-information-share-capital-and-voting-rights-as-of-31-August-2024